Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Beyond T2DM, the Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes trial is assessing whether GLP-1 RAs can meaningfully reduce MACE, HF hospitalizations, and other cardiovascular endpoints in patients with type 1 diabetes, a population generally underrepresented in cardiovascular prevention studies [66]
Think aging - that's what free radicals do to your body
Novo Nordisk researchers noticed that rats injected with liraglutide began to fast, nearly starving themselves
DBTowerERoberts, editors
US$ 28.86
US$ 26.85
US$ 28.82
US$ 21.38
US$ 23.73
US$ 23.56
US$ 28.76
